Tvardi Therapeutics, Inc. (TVRD) financial statements and ratios from SEC XBRL: revenue $700000.00 (TTM), net margin -2602.0%, revenue growth -90.2% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $700000.00 |
| Net Margin | -2602.0% |
| Revenue Growth (YoY) | -90.2% |
| EPS Growth (YoY) | -84.2% |
| Price / Book | 2.08 |
| Price / Sales | 5.49 |
| Altman Z-Score | -5.85 (distress) |
| Sector P/E (Healthcare) | 21.7 |
TVRD overview · TVRD earnings · TVRD KPIs · TVRD investor relations · TVRD ownership · TVRD peers · TVRD filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.